CN109718223B - 一种胰岛细胞微胶囊及其制备方法和应用 - Google Patents
一种胰岛细胞微胶囊及其制备方法和应用 Download PDFInfo
- Publication number
- CN109718223B CN109718223B CN201910138097.5A CN201910138097A CN109718223B CN 109718223 B CN109718223 B CN 109718223B CN 201910138097 A CN201910138097 A CN 201910138097A CN 109718223 B CN109718223 B CN 109718223B
- Authority
- CN
- China
- Prior art keywords
- islet cell
- microcapsule
- islet
- mesenchymal stem
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004153 islets of langerhan Anatomy 0.000 title claims abstract description 128
- 239000003094 microcapsule Substances 0.000 title claims abstract description 118
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 210000002901 mesenchymal stem cell Anatomy 0.000 claims abstract description 80
- 238000000034 method Methods 0.000 claims abstract description 19
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 18
- 235000010413 sodium alginate Nutrition 0.000 claims description 18
- 239000000661 sodium alginate Substances 0.000 claims description 18
- 229940005550 sodium alginate Drugs 0.000 claims description 18
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 239000011259 mixed solution Substances 0.000 claims description 5
- 239000002775 capsule Substances 0.000 claims description 3
- 241000282887 Suidae Species 0.000 claims description 2
- 210000001185 bone marrow Anatomy 0.000 claims description 2
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 210000003954 umbilical cord Anatomy 0.000 claims description 2
- 206010021143 Hypoxia Diseases 0.000 abstract description 13
- 206010012601 diabetes mellitus Diseases 0.000 abstract description 12
- 238000002054 transplantation Methods 0.000 abstract description 11
- 210000000683 abdominal cavity Anatomy 0.000 abstract description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 6
- 230000001900 immune effect Effects 0.000 abstract description 5
- 102000004877 Insulin Human genes 0.000 abstract description 3
- 108090001061 Insulin Proteins 0.000 abstract description 3
- 229940125396 insulin Drugs 0.000 abstract description 3
- 235000003170 nutritional factors Nutrition 0.000 abstract description 3
- 210000000496 pancreas Anatomy 0.000 abstract description 3
- 210000003660 reticulum Anatomy 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 235000015097 nutrients Nutrition 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000004043 dyeing Methods 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 235000003642 hunger Nutrition 0.000 description 5
- 230000008439 repair process Effects 0.000 description 5
- 230000000638 stimulation Effects 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 4
- 238000011580 nude mouse model Methods 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000592 Artificial Cell Substances 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699660 Mus musculus Species 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 101710113649 Thyroid peroxidase Proteins 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000006909 anti-apoptosis Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000016097 disease of metabolism Diseases 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 210000000569 greater omentum Anatomy 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000002894 multi-fate stem cell Anatomy 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910138097.5A CN109718223B (zh) | 2019-02-25 | 2019-02-25 | 一种胰岛细胞微胶囊及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910138097.5A CN109718223B (zh) | 2019-02-25 | 2019-02-25 | 一种胰岛细胞微胶囊及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109718223A CN109718223A (zh) | 2019-05-07 |
CN109718223B true CN109718223B (zh) | 2020-01-10 |
Family
ID=66300087
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910138097.5A Active CN109718223B (zh) | 2019-02-25 | 2019-02-25 | 一种胰岛细胞微胶囊及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109718223B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116492448A (zh) * | 2023-04-12 | 2023-07-28 | 深圳赛保尔生物药业有限公司 | 负载peg-epo及间充质干细胞的组合物、药物及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102218161A (zh) * | 2010-12-16 | 2011-10-19 | 南京大学医学院附属鼓楼医院 | 猪肝细胞与骨髓间充质干细胞共微囊化内置生物人工肝方法 |
CN103122348A (zh) * | 2012-09-20 | 2013-05-29 | 天津卫凯生物工程有限公司 | 一种胰岛微胶囊、一种胰岛模型、制备方法及用途 |
CN104450605A (zh) * | 2014-11-26 | 2015-03-25 | 荆东辉 | 一种液体微胶囊包埋、分化全能干细胞成心肌细胞的方法 |
-
2019
- 2019-02-25 CN CN201910138097.5A patent/CN109718223B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102218161A (zh) * | 2010-12-16 | 2011-10-19 | 南京大学医学院附属鼓楼医院 | 猪肝细胞与骨髓间充质干细胞共微囊化内置生物人工肝方法 |
CN103122348A (zh) * | 2012-09-20 | 2013-05-29 | 天津卫凯生物工程有限公司 | 一种胰岛微胶囊、一种胰岛模型、制备方法及用途 |
CN104450605A (zh) * | 2014-11-26 | 2015-03-25 | 荆东辉 | 一种液体微胶囊包埋、分化全能干细胞成心肌细胞的方法 |
Non-Patent Citations (4)
Title |
---|
Application of cell encapsulation for controlled delivery of biological therapeutics;G.Orive;《Advanced Drug Delivery Reviews》;20140410;第67-68卷;第3-14页 * |
Bone Marrow–Derived Mesenchymal Stem Cells Improve Islet Graft Function in Diabetic Rats;M.Figliuzzi;《Transplantation Proceedings》;20090630;第41卷(第5期);第1797-1800页 * |
Co-transplantation of islets with mesenchymal stem cells in microcapsules demonstrates graft outcome can be improved in an isolated-graft model of islet transplantation in mice;Alan Kerby;《Cytotherapy》;20130228;第15卷(第2期);第192-200页 * |
骨髓间充质干细胞和体细胞的共微囊化研究;叶莉;《中国优秀硕士学位论文全文数据库(电子期刊)》;20121230(第6期);第66-76页 * |
Also Published As
Publication number | Publication date |
---|---|
CN109718223A (zh) | 2019-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5578314A (en) | Multiple layer alginate coatings of biological tissue for transplantation | |
US5429821A (en) | Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use | |
Sun | [51] Microencapsulation of pancreatic islet cells: A bioartificial endocrine pancreas | |
US5656468A (en) | Cells or tissue coated with non-fibrogenic alginate less than 200 μm thick | |
Aebischer et al. | Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution | |
US5876742A (en) | Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method of preparation thereof | |
US6365385B1 (en) | Methods of culturing and encapsulating pancreatic islet cells | |
KR100474803B1 (ko) | 거대캡슐화 분비세포 | |
US5741685A (en) | Parenchymal cells packaged in immunoprotective tissue for implantation | |
Sakai et al. | Development of mammalian cell-enclosing subsieve-size agarose capsules (< 100 μm) for cell therapy | |
CN109892319B (zh) | 一种用于猪胰岛细胞的冻存复苏方法及冻存液和复苏液 | |
JP3291297B2 (ja) | 生物人工内分泌装置 | |
TW200920328A (en) | Therapeutic hybrid implantable devices | |
AU2007245005A1 (en) | Multi-membrane immunoisolation system for cellular transplant | |
CN111135337B (zh) | 一种含有微藻凝胶的伤口修复用敷料及其使用方法 | |
EP3528860B1 (en) | Cell associated scaffolds for delivery of agents | |
CN109718223B (zh) | 一种胰岛细胞微胶囊及其制备方法和应用 | |
Maria-Engler et al. | Microencapsulation and tissue engineering as an alternative treatment of diabetes | |
CN110464880B (zh) | 一种人工胰岛或人工胰腺及其制备方法 | |
US6645488B2 (en) | Microencapsulated pheochromocyte of ox adrenal medulla as medicine for curing pain | |
Falorni et al. | Culture maintenance of isolated adult porcine pancreatic islets in three-dimensional gel matrices: morphologic and functional results | |
Zhou et al. | Microencapsulation of rat islets prolongs xenograft survival in diabetic mice | |
CN1098690C (zh) | 微囊化牛肾上腺髓质嗜铬细胞用于制备用于治疗帕金森病药物的用途 | |
Kawakami et al. | Prolonged effect of troglitazone (CS-045) on xenograft survival of hybrid artificial pancreas | |
Bochenek | Immuno-isolation strategies for islet transplantation into rodent and non-human primate models |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Islet cell microcapsule and its preparation method and Application Effective date of registration: 20201229 Granted publication date: 20200110 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2020980010070 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230105 Granted publication date: 20200110 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2020980010070 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A microencapsulation of islet cells and its preparation method and application Effective date of registration: 20230112 Granted publication date: 20200110 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2023980031055 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20231124 Granted publication date: 20200110 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2023980031055 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A pancreatic islet cell microcapsule and its preparation method and application Effective date of registration: 20231129 Granted publication date: 20200110 Pledgee: Jinzhou Branch of Hunan Ningxiang Rural Commercial Bank Co.,Ltd. Pledgor: HUNAN XENO LIFE SCIENCE Co.,Ltd. Registration number: Y2023980068297 |